Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation

Table 4 Hepatic epithelioid hemangioendothelioma treatment results summary

Ref.	Year (analyzed period)	Source	Patients		Survival percentage
					OLTx	Liver resection	Chemio radio therapy	TACE	No treatment	All
Recent report	2013 (1989-2013)	Single center	10	3-yr	87.5%	-	-	-	-	-
Rodrigue et al[25]	2008	UNOS	110	1-yr	80%	-	-	-	-	-
				3-yr	68%
				5-yr	64%
Lerut et al[24]	2007	ELTR	59	1-yr	93%	-	-	-	-	-
				5-yr	83%
				10-yr	72%
Mehrabi et al[22]	2006 (1984-2005)	Meta-analysis	286	1-yr	96%	100%	72%	-	40%	83.4%
				3-yr	80%	87%	49%		12%	55.8%
				5-yr	54.5%	75%	30%		4.5%	41.1%
Wang et al[26]	2012 (2004-2011)	Single center	33	3-yr	-	74.1%	-	81.6%	-	73.3%
Grotz et al[27]	2010 (1984-2007)	Single center	30	1-yr	91%	100%	57%	-	57%	-
				3-yr	73%	86%	43%		43%
				5-yr	73%	86%	29%		29%
				10-yr	42.2%	86%	-		-
Nudo et al[28]	2008 (1991-2005)	Multi center	11	5-yr	82%	-	-	-	-	-

OLTx: Orthotopic liver transplantations; TACE: Transarterial chemoembolization; UNOS: United Network for Organ Sharing; ELTR: European Liver Transplant Registry.